Myozenin is a newly identified 32-kDa alpha-actinin- and gamma-filamin-binding Z line protein expressed predominantly in skeletal muscle, mapping to human chromosome 10q22.1-q22.2.
Myozenin is a newly identified skeletal muscle Z line protein that interacts with alpha-actinin and gamma-filamin, representing a potential candidate gene for neuromuscular disorders.
To better understand the structure and function of Z lines, we used sarcomeric isoforms of alpha-actinin and gamma-filamin to screen a human skeletal muscle cDNA library for interacting proteins by using the yeast two-hybrid system. Here we describe myozenin (MYOZ), an alpha-actinin- and gamma-filamin-binding Z line protein expressed predominantly in skeletal muscle. Myozenin is predicted to be a 32-kDa, globular protein with a central glycine-rich domain flanked by alpha-helical regions with no strong homologies to any known genes. The MYOZ gene has six exons and maps to human chromosome 10q22.1-q22.2. Northern blot analysis demonstrated that this transcript is expressed primarily in skeletal muscle with significantly lower levels of expression in several other tissues. Antimyozenin antisera stain skeletal muscle in a sarcomeric pattern indistinguishable from that seen by using antibodies for alpha-actinin, and immunogold electron microscopy confirms localization specifically to Z lines. Thus, myozenin is a skeletal muscle Z line protein that may be a good candidate gene for limb-girdle muscular dystrophy or other neuromuscular disorders.
Takada et al. (2001) studied this question. Myozenin is a newly identified 32-kDa alpha-actinin- and gamma-filamin-binding Z line protein expressed predominantly in skeletal muscle, mapping to human chromosome 10q22.1-q22.2.